1. Home
  2. BHE vs PBLS Comparison

BHE vs PBLS Comparison

Compare BHE & PBLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Benchmark Electronics Inc.

BHE

Benchmark Electronics Inc.

HOLD

Current Price

$81.10

Market Cap

3.1B

Sector

Technology

ML Signal

HOLD

Logo Parabilis Medicines Inc. Common Stock

PBLS

Parabilis Medicines Inc. Common Stock

N/A

Current Price

$31.28

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BHE
PBLS
Founded
1979
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.6B
IPO Year
1996
2026

Fundamental Metrics

Financial Performance
Metric
BHE
PBLS
Price
$81.10
$31.28
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$55.00
N/A
AVG Volume (30 Days)
477.6K
502.7K
Earning Date
04-29-2026
N/A
Dividend Yield
0.94%
N/A
EPS Growth
N/A
N/A
EPS
0.36
N/A
Revenue
$2,659,108,000.00
N/A
Revenue This Year
$7.03
N/A
Revenue Next Year
$6.57
N/A
P/E Ratio
$232.92
N/A
Revenue Growth
0.11
N/A
52 Week Low
$34.44
$25.56
52 Week High
$100.41
$33.65

Technical Indicators

Market Signals
Indicator
BHE
PBLS
Relative Strength Index (RSI) 44.68 56.52
Support Level $79.59 $26.83
Resistance Level $88.27 $33.65
Average True Range (ATR) 3.34 2.62
MACD -0.22 0.14
Stochastic Oscillator 60.11 63.76

Price Performance

Historical Comparison
BHE
PBLS

About BHE Benchmark Electronics Inc.

Benchmark Electronics Inc is engaged in product designing, engineering services, technology solutions, and manufacturing services (electronic manufacturing services (EMS) and precision technology services). It serves various industries, including aerospace & defense (A&D), medical technologies, complex industrials, semiconductor capital equipment, next-generation telecommunications, and high-end computing. Its geographical segments are the Americas, Asia, and Europe, of which key revenue is derived from the Americas.

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

Share on Social Networks: